Metraipolis › archive › dc_960883b5fb61
Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS) — Europe PMC PMID:42925385
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42925385
- DOI
- 10.1007/s12026-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T20:24:28.486Z
- SHA-256 of the archived text
2df54008382051d7d8c024fc5789bbadc77ad3c9e51e98c7bbf004aa3db4dc57- Stable URL of this page
https://metraipolis.com/documento/dc_960883b5fb61
How to cite
Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS) — Europe PMC PMID:42925385 — Europe PMC (en), https://europepmc.org/article/MED/42925385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_960883b5fb61 (Metraipolis archive dc_960883b5fb61, sha256 2df54008382051d7d8c024fc5789bbadc77ad3c9e51e98c7bbf004aa3db4dc57)
BibTeX
@misc{dc960883b5fb61,
title = {Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS) — Europe PMC PMID:42925385},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42925385},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_960883b5fb61; sha256 2df54008382051d7d8c024fc5789bbadc77ad3c9e51e98c7bbf004aa3db4dc57},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42925385. Agents can read the archived copy with the MCP tool read_document.